These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25443349)
1. Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C. Kumar S; Jacobson IM J Hepatol; 2014 Nov; 61(1 Suppl):S91-7. PubMed ID: 25443349 [TBL] [Abstract][Full Text] [Related]
2. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. Omata M; Nishiguchi S; Ueno Y; Mochizuki H; Izumi N; Ikeda F; Toyoda H; Yokosuka O; Nirei K; Genda T; Umemura T; Takehara T; Sakamoto N; Nishigaki Y; Nakane K; Toda N; Ide T; Yanase M; Hino K; Gao B; Garrison KL; Dvory-Sobol H; Ishizaki A; Omote M; Brainard D; Knox S; Symonds WT; McHutchison JG; Yatsuhashi H; Mizokami M J Viral Hepat; 2014 Nov; 21(11):762-8. PubMed ID: 25196837 [TBL] [Abstract][Full Text] [Related]
3. Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis C. D'Ambrosio R; Aghemo A; Colombo M Expert Opin Drug Saf; 2015 Mar; 14(3):473-84. PubMed ID: 25645644 [TBL] [Abstract][Full Text] [Related]
4. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK; Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285 [TBL] [Abstract][Full Text] [Related]
5. The rapid evolution of treatment strategies for hepatitis C. Muir AJ Am J Gastroenterol; 2014 May; 109(5):628-35; quiz 636. PubMed ID: 24732866 [TBL] [Abstract][Full Text] [Related]
6. Beyond sofosbuvir: what opportunity exists for a better nucleoside/nucleotide to treat hepatitis C? Sofia MJ Antiviral Res; 2014 Jul; 107():119-24. PubMed ID: 24792751 [TBL] [Abstract][Full Text] [Related]
7. All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (nuclear). Lawitz EJ; Rodriguez-Torres M; Denning J; Mathias A; Mo H; Gao B; Cornpropst MT; Berrey MM; Symonds WT J Viral Hepat; 2013 Oct; 20(10):699-707. PubMed ID: 24010644 [TBL] [Abstract][Full Text] [Related]
8. Sofosbuvir as backbone of interferon free treatments. Bourlière M; Oules V; Ansaldi C; Adhoute X; Castellani P Dig Liver Dis; 2014 Dec; 46 Suppl 5():S212-20. PubMed ID: 25453869 [TBL] [Abstract][Full Text] [Related]
9. Sofosbuvir for the treatment of hepatitis C virus. Asselah T Expert Opin Pharmacother; 2014 Jan; 15(1):121-30. PubMed ID: 24289735 [TBL] [Abstract][Full Text] [Related]
10. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C. Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848 [No Abstract] [Full Text] [Related]
11. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839 [TBL] [Abstract][Full Text] [Related]
12. No compelling reason to adopt new antivirals whenever it is reasonable to wait. Prescrire Int; 2015 Jan; 24(156):8. PubMed ID: 25729821 [No Abstract] [Full Text] [Related]
13. Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. Berden FA; Kievit W; Baak LC; Bakker CM; Beuers U; Boucher CA; Brouwer JT; Burger DM; van Erpecum KJ; van Hoek B; Hoepelman AI; Honkoop P; Kerbert-Dreteler MJ; de Knegt RJ; Koek GH; van Nieuwkerk CM; van Soest H; Tan AC; Vrolijk JM; Drenth JP Neth J Med; 2014 Oct; 72(8):388-400. PubMed ID: 25387551 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C genotype 1. Foster GR; De Silva S Curr Opin Infect Dis; 2014 Dec; 27(6):535-9. PubMed ID: 25304394 [TBL] [Abstract][Full Text] [Related]
19. Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series. Cornella SL; Stine JG; Kelly V; Caldwell SH; Shah NL Postgrad Med; 2015 May; 127(4):413-7. PubMed ID: 25746436 [TBL] [Abstract][Full Text] [Related]
20. Sofosbuvir: first global approval. Keating GM; Vaidya A Drugs; 2014 Feb; 74(2):273-82. PubMed ID: 24442794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]